| BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk |
NCT01704378: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 89 | Europe | biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/03 | 03/03 | | |
NCT01697631: Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes |
|
|
| Completed | 4 | 131 | Europe | biphasic insulin aspart 30, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 04/03 | 04/03 | | |
NCT01467401: Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 292 | Europe | biphasic insulin aspart, biphasic human insulin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 05/03 | 05/03 | | |
REACH , NCT01487798: Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes |
|
|
| Completed | 4 | 170 | Europe | biphasic human insulin 30, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 11/03 | 11/03 | | |
NCT00605111: Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 193 | RoW | biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/04 | 10/04 | | |
NCT00791895: Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs |
|
|
| Completed | 4 | 102 | US | biphasic insulin aspart 30, BIASP, NovoLog® Mix 70/30, NovoMix® | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/04 | 11/04 | | |
NCT00592969: Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes |
|
|
| Completed | 4 | 164 | RoW | metformin, biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 11/04 | 11/04 | | |
NCT00600366: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 71 | RoW | biphasic insulin aspart, BIASP, NovoMix 30, NovoLog 70/30 Mix | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 01/05 | 01/05 | | |
EUROMIX, NCT00619697: Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes |
|
|
| Completed | 4 | 260 | Europe | biphasic insulin aspart, BIASP, NovoMix 30, NovoLog 70/30 Mix, insulin glargine, metformin, glimepiride | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/05 | 03/05 | | |
NCT00624364: Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes |
|
|
| Completed | 4 | 140 | RoW | biphasic insulin aspart, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 05/05 | 05/05 | | |
NCT00184626: Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. |
|
|
| Completed | 4 | 97 | RoW | biphasic insulin aspart, insulin glargine, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/05 | 10/05 | | |
NCT01486862: Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs |
|
|
| Completed | 4 | 26 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 07/06 | 07/06 | | |
NCT00282451: Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes |
|
|
| Completed | 4 | 79 | RoW | biphasic insulin aspart, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 08/06 | 08/06 | | |
NCT00469092 / 2006-003288-29: Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 480 | Europe, RoW | biphasic insulin aspart, insulin glargine, metformin, glimepiride | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 04/08 | 04/08 | | |
IMPROVE, NCT00537277: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs |
|
|
| Completed | 4 | 161 | RoW | biphasic insulin aspart, BIasp, NovoLog Mix 70/30, NovoMix 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 01/09 | 01/09 | | |
S019, NCT00393705 / 2006-003076-35: Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 |
|
|
| Completed | 4 | 302 | Europe, RoW | Insulin Biphasic Aspart 30/70, insulin lispro LM, Low Mix, Humalog, insulin lispro MM, Mid Mix | Eli Lilly and Company | Diabetes Mellitus, Type 2 | 03/09 | 03/09 | | |
NCT00669864: Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin |
|
|
| Completed | 4 | 293 | RoW | biphasic insulin aspart 30, NovoMix® 30, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 04/09 | 04/09 | | |
NCT00807092: Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 145 | RoW | biphasic insulin aspart 30, biphasic human insulin 30, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/09 | 10/09 | | |
EasyMix, NCT01123980: Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment |
|
|
| Completed | 4 | 521 | Japan, RoW | biphasic insulin aspart 30, metformin, glimepiride, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 06/11 | 06/11 | | |
|
NCT01889095: Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients |
|
|
| Completed | 4 | 160 | RoW | BIAsp 30, Novomix 30, NPH/Reg | Tehran University of Medical Sciences | Diabetes Type 2 | 08/11 | 07/12 | | |
NCT01278160: Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756 |
|
|
| Completed | 4 | 179 | RoW | biphasic insulin aspart 30, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 09/11 | 09/11 | | |
NCT01068652: Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs |
|
|
| Completed | 4 | 403 | RoW | insulin detemir, insulin aspart, biphasic insulin aspart 30, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 05/12 | 05/12 | | |
B to B, NCT01212913: Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) |
|
|
| Completed | 4 | 161 | RoW | INSULIN GLARGINE, Lantus, INSULIN GLULISINE, Apidra, Insulin aspart, NovoMix 30 | Sanofi | Diabetes Mellitus, Type 2 | 05/12 | 05/12 | | |
| Terminated | 4 | 52 | Europe | Insulin glulisine, Apidra®, Insulin glargine, Lantus®, Premixed insulin (Insulin Aspart 30/70 ), NovoMix 30/70® | Sanofi | Diabetes Mellitus, Type 2 | 07/12 | 07/12 | | |
SimpleMix, NCT01427920 / 2010-024303-27: Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 348 | Europe, RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 07/12 | 07/12 | | |
NCT01215435: Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone |
|
|
| Completed | 4 | 245 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 09/12 | 09/12 | | |
NCT01618214: Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 344 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 01/13 | 01/13 | | |
| Completed | 4 | 582 | Europe, RoW | biphasic insulin aspart 30, sitagliptin, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/13 | 10/13 | | |
NCT01589653: Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients |
|
|
| Completed | 4 | 155 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 07/15 | 07/15 | | |
COMPAR, NCT02219750: Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients |
|
|
| Completed | 4 | 181 | RoW | switch twice-daily insulin, NovoMix® 30 Penfill®, lantus®, levemir®, NovoRapid® | Mackay Memorial Hospital | Diabetes | 08/15 | 08/16 | | |
NCT02453685 / 2014-003708-62: A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients |
|
|
| Completed | 4 | 335 | Europe, RoW | biphasic insulin aspart 30, insulin glargine, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 09/16 | 09/16 | | |
NCT02449603: Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes |
|
|
| Completed | 4 | 150 | RoW | Exenatide, Byetta, Biphasic insulin Aspart 30 | Xijing Hospital, Air Force Military Medical University, China, First Affiliated Hospital Xi'an Jiaotong University, Second Affiliated Hospital of Xi'an Jiaotong University, Shaanxi Provincial People's Hospital, Chang'An Hospital, Xi'an Gaoxin Hospital, Xi'an Central Hospital, Shaanxi Aerospace Hospital | Type 2 Diabetes Mellitus | 04/18 | 04/18 | | |
